Literature DB >> 7042138

Macrophage-lymphocyte interaction in response to a bacterial antigen (E. coli).

M Eibl, J W Mannhalter, R Ahmad.   

Abstract

The interactions of human lymphocytes with autologous macrophages in response to a clinically relevant particulate bacterial antigen (E coli) have been investigated. Macrophages were required as accessory cells for the E coli induced activation of both T and B lymphocytes. Lymphocyte activation was assayed by determining the degree of proliferation (measured by 3H-thymidine incorporation). The proliferative response was dependent on the number of macrophages and on the amount of antigen in the culture. Macrophages briefly exposed to E. coli acquired the ability to stimulate unfractionated lymphocytes, T and B cells in the absence of free antigen. The in vitro kinetics of this reaction has been determined and analysed with respect to polyclonal B cell response and the antigen specific T cell response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042138      PMCID: PMC1536551     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro.

Authors:  W Knapp; G Baumgartner
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity.

Authors:  D R Webb; I Nowowiejski
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  The regulation of lymphocyte functions by the macrophage.

Authors:  E R Unanue
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

5.  Specific absorption of T lymphocytes committed to soluble protein antigens by incubation on antigen-pulsed macrophage monolayers.

Authors:  O Werdelin; O Braendstrup; E M Shevach
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex.

Authors:  A G Farr; J M Kiely; E R Unanue
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

7.  Macrophage/T-lymphocyte interaction in the immune response to PPD in humans.

Authors:  B O Bergholtz; E Thorsby
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

8.  Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes.

Authors:  J J Ellner; P E Lipsky; A S Rosenthal
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

9.  Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells.

Authors:  S A Rosenberg; P E Lipsky
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

10.  [Inhibition of opsonization of E. coli by enzyme-treated gammaglobulin (author's transl)].

Authors:  M Eibl; G Friers
Journal:  Wien Klin Wochenschr       Date:  1978-10-27       Impact factor: 1.704

View more
  3 in total

1.  Collaboration of bovine T lymphocytes and macrophages in T-lymphocyte response to Brucella abortus.

Authors:  G A Splitter; K M Everlith
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation.

Authors:  J W Mannhalter; H O Neychev; G J Zlabinger; R Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

3.  Human T cell proliferation in response to E. coli presented by autologous macrophages is antigen specific.

Authors:  J W Mannhalter; G J Zlabinger; R Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.